375 related articles for article (PubMed ID: 19407487)
21. MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer.
Chen MB; Wei MX; Han JY; Wu XY; Li C; Wang J; Shen W; Lu PH
Cell Signal; 2014 Jan; 26(1):102-9. PubMed ID: 23899558
[TBL] [Abstract][Full Text] [Related]
22. AMPK Causes Cell Cycle Arrest in LKB1-Deficient Cells via Activation of CAMKK2.
Fogarty S; Ross FA; Vara Ciruelos D; Gray A; Gowans GJ; Hardie DG
Mol Cancer Res; 2016 Aug; 14(8):683-95. PubMed ID: 27141100
[TBL] [Abstract][Full Text] [Related]
23. Antiplatelet effect of AMP-activated protein kinase activator and its potentiation by the phosphodiesterase inhibitor dipyridamole.
Liu Y; Oh SJ; Chang KH; Kim YG; Lee MY
Biochem Pharmacol; 2013 Oct; 86(7):914-25. PubMed ID: 23876340
[TBL] [Abstract][Full Text] [Related]
24. CaMKKβ is involved in AMP-activated protein kinase activation by baicalin in LKB1 deficient cell lines.
Ma Y; Yang F; Wang Y; Du Z; Liu D; Guo H; Shen J; Peng H
PLoS One; 2012; 7(10):e47900. PubMed ID: 23110126
[TBL] [Abstract][Full Text] [Related]
25. AICAR, an AMPK activator, protects against cisplatin-induced acute kidney injury through the JAK/STAT/SOCS pathway.
Tsogbadrakh B; Ryu H; Ju KD; Lee J; Yun S; Yu KS; Kim HJ; Ahn C; Oh KH
Biochem Biophys Res Commun; 2019 Feb; 509(3):680-686. PubMed ID: 30616891
[TBL] [Abstract][Full Text] [Related]
26. Phenformin and 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR) activation of AMP-activated protein kinase inhibits transepithelial Na+ transport across H441 lung cells.
Woollhead AM; Scott JW; Hardie DG; Baines DL
J Physiol; 2005 Aug; 566(Pt 3):781-92. PubMed ID: 15919715
[TBL] [Abstract][Full Text] [Related]
27. AMP-activated protein kinase negatively regulates FcεRI-mediated mast cell signaling and anaphylaxis in mice.
Hwang SL; Li X; Lu Y; Jin Y; Jeong YT; Kim YD; Lee IK; Taketomi Y; Sato H; Cho YS; Murakami M; Chang HW
J Allergy Clin Immunol; 2013 Sep; 132(3):729-736.e12. PubMed ID: 23587332
[TBL] [Abstract][Full Text] [Related]
28. Apigenin, a chemopreventive bioflavonoid, induces AMP-activated protein kinase activation in human keratinocytes.
Tong X; Smith KA; Pelling JC
Mol Carcinog; 2012 Mar; 51(3):268-79. PubMed ID: 21538580
[TBL] [Abstract][Full Text] [Related]
29. Phosphatidylinositol ether lipid analogues induce AMP-activated protein kinase-dependent death in LKB1-mutant non small cell lung cancer cells.
Memmott RM; Gills JJ; Hollingshead M; Powers MC; Chen Z; Kemp B; Kozikowski A; Dennis PA
Cancer Res; 2008 Jan; 68(2):580-8. PubMed ID: 18199555
[TBL] [Abstract][Full Text] [Related]
30. Inactivation of AMPK alters gene expression and promotes growth of prostate cancer cells.
Zhou J; Huang W; Tao R; Ibaragi S; Lan F; Ido Y; Wu X; Alekseyev YO; Lenburg ME; Hu GF; Luo Z
Oncogene; 2009 May; 28(18):1993-2002. PubMed ID: 19347029
[TBL] [Abstract][Full Text] [Related]
31. The influence of the BRAF V600E mutation in thyroid cancer cell lines on the anticancer effects of 5-aminoimidazole-4-carboxamide-ribonucleoside.
Choi HJ; Kim TY; Chung N; Yim JH; Kim WG; Kim JA; Kim WB; Shong YK
J Endocrinol; 2011 Oct; 211(1):79-85. PubMed ID: 21795305
[TBL] [Abstract][Full Text] [Related]
32. The Ca2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases.
Hurley RL; Anderson KA; Franzone JM; Kemp BE; Means AR; Witters LA
J Biol Chem; 2005 Aug; 280(32):29060-6. PubMed ID: 15980064
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of CYP2E1 induces HepG2 cells death by the AMP kinase activator 5'-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR).
Zhuge J
Cell Biol Toxicol; 2009 Jun; 25(3):253-63. PubMed ID: 18473182
[TBL] [Abstract][Full Text] [Related]
34. AICAR and compound C negatively modulate HCC-induced primary human hepatic stellate cell activation in vitro.
Böttcher K; Longato L; Marrone G; Mazza G; Ghemtio L; Hall A; Luong TV; Caruso S; Viollet B; Zucman-Rossi J; Pinzani M; Rombouts K
Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G543-G556. PubMed ID: 33406006
[TBL] [Abstract][Full Text] [Related]
35. Involvement of AMP-activated protein kinase and p38 mitogen-activated protein kinase in 8-Cl-cAMP-induced growth inhibition.
Han JH; Ahn YH; Choi KY; Hong SH
J Cell Physiol; 2009 Jan; 218(1):104-12. PubMed ID: 18756496
[TBL] [Abstract][Full Text] [Related]
36. AMP-activated protein kinase contributes to zinc-induced neuronal death via activation by LKB1 and induction of Bim in mouse cortical cultures.
Eom JW; Lee JM; Koh JY; Kim YH
Mol Brain; 2016 Feb; 9():14. PubMed ID: 26856538
[TBL] [Abstract][Full Text] [Related]
37. 5-aminoimidazole-4-carboxamide riboside enhances effect of ionizing radiation in PC3 prostate cancer cells.
Isebaert SF; Swinnen JV; McBride WH; Begg AC; Haustermans KM
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1515-23. PubMed ID: 21944462
[TBL] [Abstract][Full Text] [Related]
38. Activation of AMP-activated protein kinase (AMPK) inhibits fatty acid synthesis in bovine mammary epithelial cells.
McFadden JW; Corl BA
Biochem Biophys Res Commun; 2009 Dec; 390(3):388-93. PubMed ID: 19747896
[TBL] [Abstract][Full Text] [Related]
39. Nifedipine inhibits vascular smooth muscle cell proliferation and reactive oxygen species production through AMP-activated protein kinase signaling pathway.
Sung JY; Choi HC
Vascul Pharmacol; 2012; 56(1-2):1-8. PubMed ID: 21708289
[TBL] [Abstract][Full Text] [Related]
40. Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase.
Hawley SA; Pan DA; Mustard KJ; Ross L; Bain J; Edelman AM; Frenguelli BG; Hardie DG
Cell Metab; 2005 Jul; 2(1):9-19. PubMed ID: 16054095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
